1 - Orthographic words (Tokens) |
FreP |
1, 2, 3 |
(Handler et al., 2004; Infarmed, 2012; Institute for safe medication practice, 2011)11. Handler SM, Nace DA, Studenski SA, Fridsma DB. Medication error reporting in long-term care. Am J Geriatr Pharmacother 2004; 2(3):190-196.,22. Infarmed. Deliberação n.º144/CD/2012 - Norma orientadora para a aceitação de nomes de medicamentos. [Resolution no. 144 /CD/2012 - Guiding norm for the acceptance of the medicines names]; 2012. [accessed 2014 July 11]. Available at: http://www.infarmed.pt/portal/page/portal/INFARMED/MEDICAMENTOS_USO_HUMANO/AUTORIZACAO_DE_INTRODUCAO_NO_MERCADO/144_DAM_91.pdf http://www.infarmed.pt/portal/page/porta...
,44. Institute for safe medication practice. ISMP';s List of confused drug names; 2011. [accessed 2014 July 14]. Available at: https://www.ismp.org/tools/confuseddrug names.pdf https://www.ismp.org/tools/confuseddrugn...
|
2 - Letters |
MS Word
|
2, 3 |
(Lambert et al., 2005)1212. Lambert BL, Lin SJ, Tan H. Designing safe drug names. Drug Saf 2005; 28(6):495-512.
|
3 - Syllables |
FreP |
2, 3 |
(Food and Drug Administration, 2010; Vigário, Martins, & Frota, 2006)99. Food and Drug Administration. Guidance for industry contents of a complete submission for the evaluation of proprietary names; 2010. [accessed 2014 June 03]. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075068.pdf http://www.fda.gov/downloads/Drugs/Guida...
,2626. Vigário M, Martins F, Frota S. A ferramenta FreP e a frequência de tipos silábicos e de classes de segmentos no Português. In: XXI National meeting of the Portuguese Association of Linguistics, 2006.
|
4 - Syllable types |
FreP |
2, 3 |
(Vigário, Martins, & Frota, 2006)2626. Vigário M, Martins F, Frota S. A ferramenta FreP e a frequência de tipos silábicos e de classes de segmentos no Português. In: XXI National meeting of the Portuguese Association of Linguistics, 2006.
|
5 - Consonants, vowels, glides, and V-slots |
FreP |
2, 3 |
(Lambert et al., 2005; Mateus & Andrade, 2000; Vigário, Freitas, & Frota, 2006)1212. Lambert BL, Lin SJ, Tan H. Designing safe drug names. Drug Saf 2005; 28(6):495-512.,1919. Mateus MH, Andrade E. The Phonology of the Portuguese. Oxford: Oxford University Press; 2000.,2727. Vigário M, Freitas MJ, Frota S. Grammar and frequency effects in the acquisition of prosodic words in European Portuguese. Lang Speech 2006; 49(2):175-203.
|
6 - Words per stress position |
FreP |
2, 3 |
(Aguiar & Vigário, 2010; Food and Drug Administration, 2010; Mateus & Andrade, 2000)99. Food and Drug Administration. Guidance for industry contents of a complete submission for the evaluation of proprietary names; 2010. [accessed 2014 June 03]. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075068.pdf http://www.fda.gov/downloads/Drugs/Guida...
,1818. Aguiar J, Vigário M. Contributo para o estudo da variação na frequência de unidades e padrões fonológicos. In: XXV National meeting of the Portuguese Association of Linguistics, 2010.,1919. Mateus MH, Andrade E. The Phonology of the Portuguese. Oxford: Oxford University Press; 2000.
|
7 - Hyphenated words |
MS Word
|
1, 2, 3 |
(Hyönä et al., 2004; Villalva, 2000)33. Hyönä J, Bertram R, Pollatsek A. Are long compound words identified serially via their constituents? Evidence from an eye-movement-contingent display change study. Mem Cognit 2004; 32(4):523-532.,55. Gonçalves C, Almeida ML. Morfologia Construcional: principais ideias, aplicação ao português e extensões necessárias. Alfa, rev. Linguíst 2014; 58(1):165-193.
|
8 - Words containing abbreviations (acronyms or initialims), numbers or symbols |
Manual |
1, 2, 3 |
(Mateus et al., 2004)3232. Mateus MH, Brito AM, Duarte I, Faria IH, Frota S, Matos G, Oliveira F, Vigário M, Villalva. Gramática da Língua Portuguesa. Lisboa, Portugal: Caminho; 2004.
|
9 - Expressions or words not allowed according to the regulatory requirements
|
MS Word
|
1 |
(Infarmed, 2012)22. Infarmed. Deliberação n.º144/CD/2012 - Norma orientadora para a aceitação de nomes de medicamentos. [Resolution no. 144 /CD/2012 - Guiding norm for the acceptance of the medicines names]; 2012. [accessed 2014 July 11]. Available at: http://www.infarmed.pt/portal/page/portal/INFARMED/MEDICAMENTOS_USO_HUMANO/AUTORIZACAO_DE_INTRODUCAO_NO_MERCADO/144_DAM_91.pdf http://www.infarmed.pt/portal/page/porta...
|